Published in J Neurochem on March 01, 1995
P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J (1998) 3.23
Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors. Proc Natl Acad Sci U S A (2005) 1.52
Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells. Br J Pharmacol (1996) 1.12
Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy. J Physiol (2001) 1.12
Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06
The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors. J Physiol (2000) 0.95
Discriminating between 5-HT₃A and 5-HT₃AB receptors. Br J Pharmacol (2013) 0.87
Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. J Physiol (1996) 0.85
Determination of the architecture of ionotropic receptors using AFM imaging. Pflugers Arch (2007) 0.84
Electrical interfacing of neurotransmitter receptor and field effect transistor. Eur Phys J E Soft Matter (2009) 0.83
Alcohol-induced serotonergic modulation: the role of histone deacetylases. Alcohol (2012) 0.82
Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes. Protein Expr Purif (2013) 0.81
Hydrophobic photolabeling studies identify the lipid-protein interface of the 5-HT3A receptor. Biochemistry (2009) 0.80
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor. Br J Pharmacol (2013) 0.76
Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery. J Pharm Bioallied Sci (2015) 0.75
Subunit rotation models activation of serotonin 5-HT3AB receptors by agonists. J Comput Aided Mol Des (2004) 0.75
Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists. J Mol Model (2006) 0.75
Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains. J Comput Aided Mol Des (2013) 0.75
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A (2009) 2.72
Molecular biology of 5-HT receptors. Neuropharmacology (1994) 2.01
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene (2011) 1.54
Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas. Oncogene (2007) 1.40
Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. J Neurochem (1994) 1.38
Chiari type I malformation and postoperative respiratory failure. Can J Anaesth (2000) 1.38
Is GABA release modulated by presynaptic receptors? Nature (1978) 1.13
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. J Neurooncol (2010) 1.10
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. Br J Cancer (2008) 1.02
Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine(3A) receptor. Mol Pharmacol (2000) 1.01
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. J Neurooncol (2011) 1.01
Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience (2005) 1.00
Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology (1997) 1.00
The major site of photoaffinity labeling of the gamma-aminobutyric acid type A receptor by [3H]flunitrazepam is histidine 102 of the alpha subunit. J Biol Chem (1996) 0.99
Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology (1996) 0.98
Differences in benzodiazepine receptor binding in Maudsley reactive and Maudsley non-reactive rats. Eur J Pharmacol (1978) 0.97
The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells. Br J Pharmacol (1991) 0.96
Somatic mutations are present in all members of the AKT family in endometrial carcinoma. Br J Cancer (2009) 0.96
Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci (1992) 0.96
The effects of benzodiazepines on K+-stimulated release of GABA. Neuropharmacology (1978) 0.91
A sensitive gas chromatographic procedure for the estimation of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain. Biochem Pharmacol (1973) 0.90
Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells. Eur J Pharmacol (1990) 0.90
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) (1999) 0.89
Impact of intracellular domain flexibility upon properties of activated human 5-HT3 receptors. Br J Pharmacol (2014) 0.89
"Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol (2005) 0.88
Facilitation of benzodiazepine binding by sodium chloride and GABA. Neuropharmacology (1978) 0.88
Molecular neurobiology of the GABAA receptor. Int Rev Neurobiol (1994) 0.87
A gas-liquid chromatographic method for the estimation of 2-phenylethylamine in rat brain tissue. Biochem Pharmacol (1977) 0.87
5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide. Neuropharmacology (1992) 0.87
Diazepam facilitates the potassium-stimulated release of [3H]-dopamine from rat striatal tissue [proceedings]. Br J Pharmacol (1979) 0.85
Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells. Mol Pharmacol (1992) 0.84
Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors. Mol Pharmacol (2000) 0.84
Solubilisation of the gamma-aminobutyric acid/benzodiazepine receptor from rat cerebellum: optimal preservation of the modulatory responses by natural brain lipids. J Neurochem (1987) 0.83
GABA(A) receptor gene expression in rat cortex: differential effects of two chronic diazepam treatment regimes. J Neurosci Res (2001) 0.83
Facilitation of specific benzodiazepine binding in rat brain membrane fragments by a number of anions. Neuropharmacology (1980) 0.83
GABA preincubation of rat brain sections increases [3H]GABA binding to the GABAA receptor and compromises the modulatory interactions. Eur J Pharmacol (1989) 0.82
The benzodiazepines. Prog Med Chem (1983) 0.81
Decreased GABA enhancement of benzodiazepine binding after a single dose of diazepam. J Neurochem (1999) 0.80
Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells. J Neurochem (1992) 0.80
Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol (1997) 0.80
Modification of pyrazoloquinolinone affinity by GABA predicts efficacy at the benzodiazepine receptor. Eur J Pharmacol (1984) 0.80
Effects of some amino acids on K+-induced release of [3H]-DA from rat striatal tissue [proceedings]. Br J Pharmacol (1980) 0.79
Effect of free fatty acids on GABAA receptor ligand binding. Biochem Pharmacol (1992) 0.79
Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol (2001) 0.79
Intracerebral hemorrhage and Moyamoya disease in pregnancy. Can J Anaesth (2000) 0.78
The effect of viloxazine hydrochloride on the transport of noradrenaline, dopamine, 5-hydroxytryptamine and gamma-amino-butyric acid in rat brain tissue. Neuropharmacology (1978) 0.78
Burst firing of cerebellar Purkinje neurones induced by benzodiazepines. Neuropharmacology (1977) 0.78
Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide. Neuropharmacology (2013) 0.78
Identification of domains in human recombinant GABAA receptors that are photoaffinity labelled by [3H]flunitrazepam and [3H]Ro15-4513. Neuropharmacology (1996) 0.77
Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatum in vitro. Proc West Pharmacol Soc (1980) 0.77
Light microscopic autoradiographic localisation in rat brain of the binding sites for the GABAA receptor antagonist [3H]SR 95531: comparison with the [3H]GABAA receptor distribution. Eur J Pharmacol (1988) 0.77
Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem Pharmacol (1992) 0.77
Target size of 5-HT3 receptors in N1E-115 neuroblastoma cells and rat brain. Eur J Pharmacol (1990) 0.77
Kinetics of [3H]Ro 15-1788 binding to membrane-bound rat brain benzodiazepine receptors. J Neurochem (1984) 0.77
The postnatal development of the benzodiazepine receptor in the cerebral cortex and cerebellum of the rat. J Neurochem (1979) 0.77
Facilitation of striatal potassium-induced dopamine release - novel structural requirements for a presynaptic action of benzodiazepines. Neuropharmacology (1980) 0.77
Analysis of amines in the central nervous system by gas chromatography with electron-capture detection. Prog Neurobiol (1981) 0.76
Solubilization of the benzodiazepine/gamma-aminobutyric acid receptor complex: comparison of the detergents octylglucopyranoside and 3-[(3-cholamidopropyl)-dimethylammonio]1-propanesulfonate (CHAPS). J Neurochem (1986) 0.76
Purification and characterization of 5-HT3 receptors from NG108-15 neuroblastoma x glioma cells. Biochem Soc Trans (1992) 0.76
Flunitrazepam increases the affinity of the GABAA receptor in cryostat-cut rat brain sections. Eur J Pharmacol (1990) 0.76
The effects of some indolalkylamines on the uptake and release of 5-hydroxytryptamine in rat striatum [proceedings]. Br J Pharmacol (1977) 0.76
Chronic diazepam exposure decreases transcription of the rat GABA(A) receptor gamma2-subunit gene. Brain Res Mol Brain Res (1997) 0.76
Dimethyl sulfoxide/propylene glycol is a suitable solvent for the delivery of diazepam from osmotic minipumps. J Pharmacol Toxicol Methods (1996) 0.76
Modification of the radioenzymatic assay for the catecholamines. Biochem Pharmacol (1978) 0.76
Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels. Br J Pharmacol (1974) 0.76
Effects of p-chloro-beta-phenylethylamine on the uptake and release of putative amine neurotransmitters in rat brain [proceedings]. Br J Pharmacol (1976) 0.75
A sensitive gas chromatographic technique for quantification of urinary tryptamine [proceedings]. Br J Pharmacol (1979) 0.75
Reversal learning facilitated by a single injection of lysergic acid diethylamide (LSD 25) in the rat. Br J Pharmacol (1972) 0.75
Gas chromatographic method for the estimation of noradrenaline, dopamine, and 5-hydroxytryptamine. Br J Pharmacol (1972) 0.75
Evidence of strain differences in GABA-benzodiazepine coupling. Psychopharmacology (Berl) (1987) 0.75
Multiple benzodiazepine receptors: structures in the brain or structures in the mind? A critical review. Life Sci (1983) 0.75
Para-chlorophenylethylamine in brains of rats treated with a monoamine oxidase inhibitor and p-chlorophenylalanine. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.75
Interactions of different ligand classes with the benzodiazepine receptor. Adv Biochem Psychopharmacol (1983) 0.75
Modulation of [3H]flunitrazepam binding to rat cerebellar benzodiazepine receptors by phosphatidylserine. Eur J Pharmacol (1987) 0.75
Determination of 5-hydroxytryptamine in rat brain regions by gas-liquid chromatography with electron-capture detection. J Pharmacol Methods (1980) 0.75
Biochemical characterization of an isolated and functionally reconstituted gamma-aminobutyric acid/benzodiazepine receptor. J Neurochem (1990) 0.75
Characterization of soluble 5-hydroxytryptamine3 receptors from N1E115 neuroblastoma cells. Biochem Soc Trans (1990) 0.75
Comparison of native 5-HT3 receptors purified from various neuroblastoma-derived cell lines and bovine brain with recombinant 5-HT3-AL receptors purified after expression in HEK293 cells. Ann N Y Acad Sci (1998) 0.75
Autoradiographic localisation of benzodiazepine receptors in the rat pituitary gland. Eur J Pharmacol (1984) 0.75
The benzodiazepines: a critical review. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
The origin of the catecholamine innervation of the sympathetic lateral column [proceedings]. J Physiol (1979) 0.75
The benzodiazepine receptor in rat brain and its interaction with ethyl beta-carboline-3-carboxylate. J Neurochem (1983) 0.75
Polyclonal antibodies to agonist benzodiazepines. Biochem Pharmacol (1987) 0.75
Rapid, sensitive procedure to determine buspirone levels in rat brains using gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl (1997) 0.75
Long-lasting anticonvulsant effects of diazepam in different mouse strains: correlations with brain concentrations and receptor occupancy. Psychopharmacology (Berl) (1985) 0.75
Interactions of beta-carbolines with the benzodiazepine receptor: structure-activity relationships. Eur J Pharmacol (1981) 0.75
The GABA-benzodiazepine receptor complex. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
Polyclonal antibodies to the glycine receptor antagonist strychnine. J Neurochem (1989) 0.75
The benzodiazepines: recent trends. Psychol Med (1982) 0.75
Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy. Neurosci Lett (1983) 0.75
Is the benzodiazepine receptor coupled to a chloride anion channel? Nature (1979) 0.75
Bulbospinal tryptaminergic neurones. A search for the role of bulbospinal tryptaminergic neurones in the control of sympathetic activity. Pflugers Arch (1978) 0.75
Solubilisation of the benzodiazepine receptor from rat cerebellum by the detergent n-octylpentaoxyethylene. J Neurochem (1987) 0.75
Photoaffinity labelling of the benzodiazepine receptor compromises the recognition site but not its effector mechanism. J Neurochem (1984) 0.75
Procedural difficulties in the gas-liquid chromatographic assay of the arylalkylamines. J Chromatogr (1976) 0.75